Mrinmayee Joshi

Mrinmayee Joshi

Auto-generated profile, based on publicly available information

Mrinmayee Joshi

Pharmacy Systems, Outcomes and Policy, University of Illinois Chicago College of Pharmacy, Chicago, USA

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 November 2023 in Annals of Pharmacotherapy
Verified
Journal Article
Closed access
MJMrinmayee Joshi
Mrinmayee Joshi
BCBrendan Clark
Brendan Clark
TLTodd A. Lee
Todd A. Lee
Objective: Several cases of Fanconi syndrome (FS), a severe form of nephrotoxicity, have been reported in patients with HIV on tenofovir-containing antiretroviral therapy. A systematic review of the published literature on tenofovir-related FS in patients with HIV was conducted. Data Sources: PubMed and Embase were queried to identify articles in English published between January 2005 and June 2023, reporting tenofovir-related FS in adults with HIV. Preclinical studies, conference/poster abstracts, commentaries and responses, and review papers were excluded. Study Selection and Data Extraction: Of the 256 articles screened, 57 met the inclusion criteria. These comprised 37 case reports, 11 case series, 1 cross-sectional study, 1 case-control study, 4 cohort studies, 1 single-arm open-label clinical trial, 1 sub-analysis of clinical trials, and 1 pooled analysis of clinical trials. Data Synthesis: Among 56 cases on which information was abstracted, median age at FS diagnosis was 50 years, 51.8% were men, and duration of tenofovir use ranged from 6 weeks to 11 years. Ritonavir was co-prescribed in almost half the cases. In observational and interventional studies, incidence of FS was low. Many studies reported resolution of FS symptoms after tenofovir discontinuation. All FS occurrences were identified in those on tenofovir disoproxil fumarate (TDF), except for one patient on tenofovir alafenamide (TAF). Relevance to Patient Care and Clinical Practice: Continuous monitoring of signs and symptoms of renal and bone toxicity is essential for patients with HIV on tenofovir-containing therapy. Conclusions: Occurrence of FS is low in patients with HIV treated with tenofovir-based regimens. Concomitant use of ritonavir may increase risk of FS. TAF may be a safer alternative than TDF in terms of nephrotoxicity.

24 September 2024 in Journal of the American Pharmacists Association
Verified
Journal Article
Closed access
MJMrinmayee Joshi
Mrinmayee Joshi
CPChristine Pham
Christine Pham
HDHuiwen Deng
Huiwen Deng
SMSheryl Mathew
Sheryl Mathew
RNRachel M. Norton
Rachel M. Norton
JTJessica J. Tilton
Jessica J. Tilton

1 June 2021 in Value in Health
Verified
Journal Article
Closed access
MJM. Joshi
M. Joshi
SAS.J. Atlas
S.J. Atlas
DRD.M. Rind
D.M. Rind
MBM. Beinfeld
M. Beinfeld
AMA. McKenna
A. McKenna
DTD. Touchette
D. Touchette

1 May 2020 in Value in Health
Verified
Journal Article
Closed access
DTD. Touchette
D. Touchette
SAS.J. Atlas
S.J. Atlas
FAF.O. Agboola
F.O. Agboola
MJM. Joshi
M. Joshi
TLT.A. Lee
T.A. Lee
DRD.M. Rind
D.M. Rind

27 September 2025 in Quality of Life Research
Verified
Journal Article
Open access
PDF file
MJMrinmayee Joshi
Mrinmayee Joshi
APA. Simon Pickard
A. Simon Pickard
KKKibum Kim
Kibum Kim
LSLisa K. Sharp
Lisa K. Sharp
BGBen S. Gerber
Ben S. Gerber
DTDaniel R. Touchette
Daniel R. Touchette
Purpose: Health-related quality of life (HRQL) assessment provides insights into the lived experiences of diverse populations. This study evaluated the convergent validity and responsiveness of the EQ-5D-3L in racial/ethnic minority populations with type 2 diabetes and elevated hemoglobin A1c (HbA1c). Methods: Secondary data from a clinical trial of a diabetes adherence support intervention for African-American and Latinx patients with type 2 diabetes (NCT02990299) were analyzed. Clinical (HbA1c, systolic blood pressure [SBP], body mass index [BMI]), psychological (brief 4-item diabetes distress scale [DDS4] for diabetes-related distress, 9-item patient health questionnaire [PHQ-9] for depressive symptoms), and HRQL (EQ-5D-3L) data were collected at baseline and every 6 months for 2 years. Convergent validity was assessed by examining the strength of associations between clinical/psychological measures and EQ-5D scores. A responder analysis using generalized estimating equation models was used to evaluate the EQ-5D's sensitivity to changes in clinical/psychological factors over time. Results: Among 221 individuals analyzed, HbA1c and SBP levels did not differ across those reporting varying levels of problems in any EQ-5D dimension. Individuals with higher BMI were more likely to report problems with mobility, usual activities, pain/discomfort, and anxiety/depression. DDS4 scores were moderately correlated with EQ-5D anxiety/depression dimension and index score, while PHQ-9 scores were strongly correlated with both. EQ-5D index score was insensitive to improvements in clinical measures but sensitive to improvements in psychological measures over time. Conclusion: The EQ-5D-3L captured variations in BMI and psychological measures but not in HbA1c and SBP. This study provides HRQL estimates that can be compared with other populations or studies.